‘Cognitive Computing as a Game Changer’ is the Session Focus by ArisGlobal at World Drug Safety Congress

Apr 24, 2017

CHICAGO, IL.  APRIL 24, 2017 — ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, will present at the World Drug Safety Congress Americas 2017 conference to be held in Philadelphia, PA from May 3 to 4, 2017, on the topic “Cognitive Computing Changes the Game in Pharmacovigilance.”

Given by Nicole Gillen, ArisGlobal, Senior Marketing Director, the presentation, scheduled for May 3, 2:05-2:25 p.m., will share how artificial intelligence (AI) and machine learning are already having an impact on our everyday lives, and, more specifically, what this will mean to a pharmacovigilance (PV) team facing a growing volume of case processing.

“Cognitive computing, which is based on artificial intelligence and machine learning, will rapidly become an important differentiator within life sciences companies as a way to more quickly analyse data and manage complex pharmacovigilance requirements,” said Nicole. “Today’s PV ecosystem often lacks the ability to easily gather actionable insights to improve safety. My presentation will help life science companies, both large and small, to gain some quick insights into how their organization and the regulatory community will benefit.”

In addition to Nicole’s presentation, ArisGlobal will be leading a peer-to-peer roundtable “Improved Information Sharing to Drive Compliance and Organizational Efficiency,” scheduled for May 4, 2017, 11:30 a.m.-12:10 p.m. ArisGlobal will be exhibiting at World Drug Safety Congress (Booth #13) and is a sponsor of the event. The annual event presents attendees with a unique forum for industry and partners to learn about the latest developments in drug safety and how they can tackle day-to-day critical. Attendees are invited to visit Nicole and attending ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.

About ArisGlobal

ArisGlobal’s cloud-based software solutions facilitate global drug development and regulatory compliance within the life sciences and healthcare industries. Its cloud platform supports the entire product life cycle including clinical development, regulatory affairs, pharmacovigilance and medical communications. Hundreds of drug and device manufacturers, CROs and regulatory agencies leverage ArisGlobal’s advanced technology solutions spanning regulatory information management, risk evaluation and mitigation strategies, medical information and clinical trial management software to make better and more informed decisions, facilitate compliance, reduce risk, and improve operational efficiency. Headquartered in the United States, ArisGlobal has regional offices in Europe, India and Japan. Visit arisglobal.com or follow us via Twitter, LinkedIn or Facebook.


About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global


Erika Thomas
+305-726-6601 | ethomas@arisglobal.com